Strategic Hub in Asia-Pacific Begins Operations as SBC Aims to Become the World’s Leading Medical Group
SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical Group,” “SBC”) today announced that its wholly owned subsidiary, SBC MEDICAL APAC PTE. LTD., established in Singapore in March 2025, has completed all required administrative procedures, including the payment of capital, and officially commenced business operations as of May 2025. The company will function as a strategic headquarters responsible for market analysis, planning and execution of new business initiatives, and the promotion of strategic partnerships in the Asia-Pacific (APAC) region. The company will be headed by Group CEO Yoshiyuki Aikawa, who will oversee both business execution and management decision making directly from Singapore.
Under the group purpose of “By medical innovation, contribute to improving the ‘well-being’ of people around the world,” SBC Medical Group provides comprehensive management support services to clinics across a wide range of medical fields, including aesthetic medicine, dentistry, hair loss treatment, gynecology, fertility treatment, ophthalmology, orthopedics, and regenerative medicine. In addition, SBC is actively promoting business diversification, including B2B services, and expanding its operations globally. In 2024, AESTHETIC HEALTHCARE HOLDINGS PTE. LTD. (“AHH”), a Singapore-based company operating aesthetic medical clinics, family clinics, and quick facial aesthetics outlets, became a member of SBC Medical Group.
SBC MEDICAL APAC PTE. LTD. has officially launched its operations as a base for market analysis, planning and promotion of new businesses, and establishment of strategic partnerships in the APAC region. Going forward, the company will serve as a strategic hub for delivering high-quality, Japan-origin aesthetic medicine to countries across the APAC region. By accelerating the expansion of local clinics and strengthening brand recognition in the region, we aim to further enhance our competitiveness in the global market and increase our overall corporate value.
About Aesthetic Healthcare Holdings Pte. Ltd.
AHH is based in Singapore and operates aesthetic medical clinics, family clinics, and quick facial aesthetics outlets. The founder, Dr. Ewen Chee, is known as one of the pioneers in the field of aesthetic medicine in Singapore and is a co-chair of the first Asia Pacific Thread Lift Conference (APEM) and a board-certified physician by the American Academy of Aesthetic Medicine. He is a frequent speaker at international conferences and workshops, and his expertise and knowledge have been featured in numerous scientific publications.
About SBC Medical
SBC Medical, headquartered in Irvine, California and Tokyo, Japan, owns and provides management services and products to cosmetic treatment centers. The Company is primarily focused on providing comprehensive management services to franchisee clinics, including but not limited to advertising and marketing needs across various platforms (such as social media networks), staff management (such as recruitment and training), booking reservations for franchisee clinic customers, assistance with franchisee employee housing rentals and facility rentals, construction and design of franchisee clinics, medical equipment and medical consumables procurement (resale), the provision of cosmetic products to franchisee clinics for resale to clinic customers, licensure of the use of patent-pending and non-patented medical technologies, trademark and brand use, IT software solutions (including but not limited to remote medical consultations), management of the franchisee clinic’s customer rewards program (customer loyalty point program), and payment tools for the franchisee clinics.
For more information, visit https://sbc-holdings.com/
Forward-Looking Statements
This press release contains forward-looking statements. Forward-looking statements are not historical facts or statements of current conditions, but instead represent only the Company’s beliefs regarding future events and performance, many of which, by their nature, are inherently uncertain and outside of the Company’s control. These forward-looking statements reflect the Company’s current views with respect to, among other things, the Company’s product launch plans and strategies; growth in revenue and earnings; and business prospects. In some cases, forward-looking statements can be identified by the use of words such as “may,” “should,” “expects,” “anticipates,” “contemplates,” “estimates,” “believes,” “plans,” “projected,” “predicts,” “potential,” “targets” or “hopes” or the negative of these or similar terms. The Company cautions readers not to place undue reliance upon any forward-looking statements, which are current only as of the date of this release and are subject to various risks, uncertainties, assumptions, or changes in circumstances that are difficult to predict or quantify. The forward-looking statements are based on management’s current expectations and are not guarantees of future performance. The Company does not undertake or accept any obligation to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions, or circumstances on which any such statement is based, except as required by law. Factors that may cause actual results to differ materially from current expectations may emerge from time to time, and it is not possible for the Company to predict all of them; such factors include, among other things, changes in global, regional, or local economic, business, competitive, market and regulatory conditions, and those listed under the heading “Risk Factors” and elsewhere in the Company’s filings with the U.S. Securities and Exchange Commission (the “SEC”), which are accessible on the SEC’s website at www.sec.gov.
Corporate Overview
Company Name: SBC MEDICAL APAC PTE. LTD.
Representative: CEO Yoshiyuki Aikawa
Address: 9 Raffles Place, #58-02, Republic Plaza, Singapore 048619
Capital: SGD 300,000
Commencement of Operations: May 2025
Contact
In Asia:
SBC Medical Group Holdings Incorporated
Hikaru Fukui / Head of Investor Relations
E-mail: ir@sbc-holdings.com
In the US:
ICR LLC
Bill Zima / Managing Partner
Email: bill.zima@icrinc.com